This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Légaré, J.-F. Articles by Hirsch, G. Search for Related Content PubMed PubMed Citation Articles by Légaré, J.-F. Articles by Hirsch, G.

(American Journal of Pathology. 2000;157:859-865.)
© 2000 American Society for Investigative Pathology

Regular Articles

CD8+ T Lymphocytes Mediate Destruction of the Vascular Media in a Model of Chronic Rejection

Jean-Francois Légaré^*, Thomas Issekutz^*, Timothy D. G. Lee^* and Greg Hirsch^*

From the Department of Surgery,^*
Victoria General Hospital, Halifax; and the Department of Microbiology and Immunology,
Dalhousie University, Halifax, Nova Scotia, Canada

Allograft arteriosclerosis is an important characteristic of chronic graft rejection. In allograft arteriosclerosis there is a striking loss of medial smooth muscle cells (SMCs) before the development of a concentric intimal proliferative response. In this study we evaluated the role of CD8+ T lymphocytes in this medial SMC loss. Brown Norway aortic segments were transplanted into Lewis animals for 60 days (long allo-exposure) or 20 days (short allo-exposure). After 20 days allogeneic exposure aortic segments were transplanted back into syngeneic (Brown Norway) animals for 40 days. Experimental animals were treated with mAb to CD8. Apoptosis was measured by terminal dUTP nick-end labeling at 20 days and morphometry analyzed at 60 days to evaluate medial and intimal changes. Anti-CD8 treatment significantly lowered CD8+ T cell counts in peripheral blood, reduced medial SMC apoptosis at 20 days, and increased medial SMC counts at 60 days. Both short- and long-allogeneic exposure groups confirmed these findings and demonstrated that medial SMC loss is proportional to the length of allogeneic exposure. Antibody depletion of CD8+ T cells results in reduced medial SMC apoptosis and better medial SMC preservation. This supports the hypothesis that medial SMC loss occurs by apoptotic death and is driven by CD8+ T lymphocytes.

This article has been cited by other articles:

				J. B.K. Schwarz, N. Langwieser, N. N. Langwieser, M. J. Bek, S. Seidl, H.-H. Eckstein, B. Lu, A. Schomig, H. Pavenstadt, and D. Zohlnhofer Novel Role of the CXC Chemokine Receptor 3 in Inflammatory Response to Arterial Injury: Involvement of mTORC1 Circ. Res., January 30, 2009; 104(2): 189 - 200. [Abstract] [Full Text] [PDF]

				R. N. Mitchell and P. Libby Vascular Remodeling in Transplant Vasculopathy Circ. Res., April 13, 2007; 100(7): 967 - 978. [Abstract] [Full Text] [PDF]

				J. C. Choy, V. H.Y. Hung, A. L. Hunter, P. K. Cheung, B. Motyka, I. S. Goping, T. Sawchuk, R. C. Bleackley, T. J. Podor, B. M. McManus, et al. Granzyme B Induces Smooth Muscle Cell Apoptosis in the Absence of Perforin: Involvement of Extracellular Matrix Degradation Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2245 - 2250. [Abstract] [Full Text] [PDF]

				J. C. Choy, A. Kerjner, B. W. Wong, B. M. McManus, and D. J. Granville Perforin Mediates Endothelial Cell Death and Resultant Transplant Vascular Disease in Cardiac Allografts Am. J. Pathol., July 1, 2004; 165(1): 127 - 133. [Abstract] [Full Text] [PDF]

				W. Luo, A. Liu, Y. Chen, H. M. Lim, J. Marshall-Neff, J. H. Black, W. Baldwin III, R. H. Hruban, S. C. Stevenson, P. Mouton, et al. Inhibition of Accelerated Graft Arteriosclerosis by Gene Transfer of Soluble Fibroblast Growth Factor Receptor-1 in Rat Aortic Transplants Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1081 - 1086. [Abstract] [Full Text] [PDF]

				R. E. Shaddy and J. A. Hawkins Immunology and failure of valved allografts in children Ann. Thorac. Surg., October 1, 2002; 74(4): 1271 - 1275. [Abstract] [Full Text] [PDF]